jpoly4

Biopharma Executive Perspectives on 2021

When our backs were against the wall, the biotech/biopharma community came together to create not one, but two vaccines currently approved for emergency use in the U.S. This has earned the industry a lot of respect.

A year in Longevity: science perspectives

Over the past year, we’ve had the pleasure of speaking to some of the Longevity sector’s most influential people. From expert views on biomarkers and interventions, the definition of biological age, the secret to healthy aging, or AI and COVID-19, we’ve put together some of our favourites.

Fountain Therapeutics Moves Corporate Headquarters to Lilly Gateway Labs in South San Francisco

Fountain Therapeutics (“Fountain”), a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing cellular age, today announced it has moved its corporate headquarters to Lilly Gateway Labs in South San Francisco upon selection by Eli Lilly and Company. The company joins a select group of emerging biotech companies spearheading innovation in drug …

Fountain Therapeutics Moves Corporate Headquarters to Lilly Gateway Labs in South San Francisco Read More »

Targeting Diseases of Aging at a Cellular Level

To see the affects of aging all you have to do is look in a mirror and watch the changes over time. Fountain Therapeutics is training its artificial intelligence platform to look at individual cells to detect changes that occur as cells get older and discover therapeutics that target underlying mechanisms of aging. 

Scroll to Top